Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids

Adipose tissue macrophages: going off track during obesity

(2016) Lily Boutens et al.   DIABETOLOGIA

Effects of homocysteine on adipocyte differentiation and CD36 gene expression in 3T3-L1 adipocytes

(2015) Ahmet Mentese et al.   Journal of Cell Communication and Signaling

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A2 Activity: A Randomized, Controlled Trial

(2014) Joel L. Johnson et al.   PLoS One

Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes

(2013) L. N. Fink et al.   DIABETOLOGIA

Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes

(2012) H. S. Schipper et al.   DIABETOLOGIA

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2

(2012) Robert S. Rosenson et al.   JOURNAL OF LIPID RESEARCH

High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects

(2011) A. L. Harte et al.   DIABETES CARE

Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study

(2011) Ana María Wägner et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Lipoprotein-Associated Phospholipase A2 Activity Predicts Progression of Subclinical Coronary Atherosclerosis

(2011) Gregory L. Kinney et al.   Diabetes Technology & Therapeutics

ITIH-5 Expression in Human Adipose Tissue Is Increased in Obesity

(2011) Åsa Anveden et al.   Obesity

Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue

(2011) Karen A. Harford et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

Darapladib and its potential for plaque stabilization and prevention of cardiac events

(2010) Harvey White   Clinical Lipidology

Lipoprotein-associated phospholipase A2 and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

(2010) T. L. Nelson et al.   DIABETOLOGIA

Role of Calcium-independent Phospholipase A2β in High Glucose-induced Activation of RhoA, Rho Kinase, and CPI-17 in Cultured Vascular Smooth Muscle Cells and Vascular Smooth Muscle Hypercontractility in Diabetic Animals

(2010) Zhongwen Xie et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes

(2009) Ming Yang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Lipoprotein-Associated Phospholipase A2

(2009) Houman Khakpour et al.   Cardiology in Review

OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways

(2009) Wen-Yi Wang et al.   CARDIOVASCULAR RESEARCH

Tenomodulin Is Highly Expressed in Adipose Tissue, Increased in Obesity, and Down-Regulated during Diet-Induced Weight Loss

(2009) Atsuhito Saiki et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Relationship of lipoprotein-associated phospholipase A2and oxidized low density lipoprotein in carotid atherosclerosis

(2009) Kasey C. Vickers et al.   JOURNAL OF LIPID RESEARCH

The Spin Stops Here: Inhibition of Lipoprotein-Associated Phospholipase A2-- A Promising Target but a Negative Initial Trial?

(2008) J. P. McConnell et al.   CLINICAL CHEMISTRY

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

(2008) Robert L Wilensky et al.   NATURE MEDICINE

p38 kinase/cytosolic phospholipase A2/cyclooxygenase-2 pathway: A new signaling cascade for lipopolysaccharide-induced interleukin-1β and interleukin-6 release in differentiated U937 cells

(2008) Xiaohui Wang et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS